BRAIN HEALTH ASSESSMENT IN MACULAR DEGENERATION PATIENTS UNDERGOING INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS (THE BHAM STUDY): An Interim Analysis
Conclusion:
Our study is the first to associate worsening cognitive health with higher cumulative anti-VEGF injections. This study was not designed to show a causal link, but does suggest that additional investigation is warranted.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Brain | Neurology | Opthalmology | Statistics | Study